U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07692867) titled 'Efficacy and Safety Study of Tunodafil Hydrochloride Tablets in Erectile Dysfunction' on June 24.
Brief Summary: This is a multicenter, randomized, double blind, placebo-controlled, parallel design study to evaluate the efficacy and safety of Tunodafil Hydrochloride Tablets in men with erectile dysfunction.
Study Start Date: April 01, 2021
Study Type: INTERVENTIONAL
Condition:
Erectile Dysfunction
Intervention:
DRUG: Tunodafil Hydrochloride Tablets 50mg
All enrolled participants will receive a 12-week treatment regimen. Researchers shall instruct participants on proper medication administration, requiring the drug to be taken...